FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122059694> ?p ?o ?g. }

• W2122059694 endingPage "185" @default.
• W2122059694 startingPage "180" @default.
• W2122059694 abstract "<h3>Objectives</h3> Osteopontin is an extracellular matrix protein with diverse immunomodulatory functions. The authors assessed the safety, tolerability, pharmacokinetics, pharmacodynamics and initial efficacy of the humanised monoclonal antibody ASK8007, which blocks osteopontin. <h3>Methods</h3> In this double-blind, multicentre, combined first-in-man, single-dose escalation (phase I, part A) and proof-of-concept, multiple-dose (phase IIA, part B) study, rheumatoid arthritis (RA) patients with active disease were randomly assigned to receive ASK8007 or placebo intravenously. Safety monitoring, pharmacokinetic and pharmacodynamic analyses and clinical assessments were performed throughout the study. The expression of phenotypic cell markers was evaluated in synovial tissue biopsy samples obtained at baseline and 43 days after initiation of treatment (part B) by immunohistochemistry and digital image analysis. Two co-primary efficacy endpoints were the change from baseline in the disease activity score evaluated in 28 joints (DAS28) and the change from baseline in the number of CD68 synovial sublining macrophages, both assessed on day 43 (part B). <h3>Results</h3> ASK8007 was overall safe and well tolerated up to the highest studied dose (20 mg/kg). Quantifiable concentrations of ASK8007 were detected in synovial fluid. No differences were observed for changes from baseline in DAS28 and CD68 sublining macrophages between ASK8007 and placebo-treated patients. Within the ASK8007 treatment group, there were also no apparent clinical responses or changes in sublining macrophages. In addition, ASK8007 treatment did not change other assessed biomarkers. <h3>Conclusions</h3> Osteopontin blockade is well tolerated and not related to safety concerns. These results consistently show that osteopontin blockade is unlikely to induce robust clinical improvement in RA patients." @default.
• W2122059694 created "2016-06-24" @default.
• W2122059694 creator A5005994370 @default.
• W2122059694 creator A5006123817 @default.
• W2122059694 creator A5012564728 @default.
• W2122059694 creator A5015068573 @default.
• W2122059694 creator A5016562414 @default.
• W2122059694 creator A5019431765 @default.
• W2122059694 creator A5021685324 @default.
• W2122059694 creator A5022116107 @default.
• W2122059694 creator A5030722966 @default.
• W2122059694 creator A5038668402 @default.
• W2122059694 creator A5051517138 @default.
• W2122059694 creator A5052453108 @default.
• W2122059694 creator A5057239837 @default.
• W2122059694 creator A5071926023 @default.
• W2122059694 creator A5088843769 @default.
• W2122059694 creator A5090277186 @default.
• W2122059694 date "2011-09-14" @default.
• W2122059694 modified "2023-10-18" @default.
• W2122059694 title "Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study" @default.
• W2122059694 cites W1507322431 @default.
• W2122059694 cites W1537511252 @default.
• W2122059694 cites W1969467934 @default.
• W2122059694 cites W1970421228 @default.
• W2122059694 cites W1972359429 @default.
• W2122059694 cites W1977283269 @default.
• W2122059694 cites W1978692741 @default.
• W2122059694 cites W1979239025 @default.
• W2122059694 cites W1985380203 @default.
• W2122059694 cites W2000905503 @default.
• W2122059694 cites W2002584410 @default.
• W2122059694 cites W2006044067 @default.
• W2122059694 cites W2006877529 @default.
• W2122059694 cites W2013326206 @default.
• W2122059694 cites W2015268764 @default.
• W2122059694 cites W2029239231 @default.
• W2122059694 cites W2037068771 @default.
• W2122059694 cites W2040502563 @default.
• W2122059694 cites W2044684335 @default.
• W2122059694 cites W2046086515 @default.
• W2122059694 cites W2077569218 @default.
• W2122059694 cites W2093863948 @default.
• W2122059694 cites W2098752045 @default.
• W2122059694 cites W2110177517 @default.
• W2122059694 cites W2118765412 @default.
• W2122059694 cites W2132981126 @default.
• W2122059694 cites W2147060846 @default.
• W2122059694 cites W2152348310 @default.
• W2122059694 cites W2159106700 @default.
• W2122059694 cites W2159901127 @default.
• W2122059694 cites W2168994208 @default.
• W2122059694 cites W2189172124 @default.
• W2122059694 doi "https://doi.org/10.1136/annrheumdis-2011-200298" @default.
• W2122059694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21917822" @default.
• W2122059694 hasPublicationYear "2011" @default.
• W2122059694 type Work @default.
• W2122059694 sameAs 2122059694 @default.
• W2122059694 citedByCount "43" @default.
• W2122059694 countsByYear W21220596942012 @default.
• W2122059694 countsByYear W21220596942013 @default.
• W2122059694 countsByYear W21220596942014 @default.
• W2122059694 countsByYear W21220596942015 @default.
• W2122059694 countsByYear W21220596942016 @default.
• W2122059694 countsByYear W21220596942017 @default.
• W2122059694 countsByYear W21220596942018 @default.
• W2122059694 countsByYear W21220596942019 @default.
• W2122059694 countsByYear W21220596942020 @default.
• W2122059694 countsByYear W21220596942021 @default.
• W2122059694 countsByYear W21220596942022 @default.
• W2122059694 countsByYear W21220596942023 @default.
• W2122059694 crossrefType "journal-article" @default.
• W2122059694 hasAuthorship W2122059694A5005994370 @default.
• W2122059694 hasAuthorship W2122059694A5006123817 @default.
• W2122059694 hasAuthorship W2122059694A5012564728 @default.
• W2122059694 hasAuthorship W2122059694A5015068573 @default.
• W2122059694 hasAuthorship W2122059694A5016562414 @default.
• W2122059694 hasAuthorship W2122059694A5019431765 @default.
• W2122059694 hasAuthorship W2122059694A5021685324 @default.
• W2122059694 hasAuthorship W2122059694A5022116107 @default.
• W2122059694 hasAuthorship W2122059694A5030722966 @default.
• W2122059694 hasAuthorship W2122059694A5038668402 @default.
• W2122059694 hasAuthorship W2122059694A5051517138 @default.
• W2122059694 hasAuthorship W2122059694A5052453108 @default.
• W2122059694 hasAuthorship W2122059694A5057239837 @default.
• W2122059694 hasAuthorship W2122059694A5071926023 @default.
• W2122059694 hasAuthorship W2122059694A5088843769 @default.
• W2122059694 hasAuthorship W2122059694A5090277186 @default.
• W2122059694 hasConcept C111113717 @default.
• W2122059694 hasConcept C112705442 @default.
• W2122059694 hasConcept C126322002 @default.
• W2122059694 hasConcept C142724271 @default.
• W2122059694 hasConcept C197934379 @default.
• W2122059694 hasConcept C204787440 @default.
• W2122059694 hasConcept C27081682 @default.
• W2122059694 hasConcept C2777575956 @default.
• W2122059694 hasConcept C2778375690 @default.
• W2122059694 hasConcept C2780804394 @default.

• next